RA
THER

Royce & Associates’s THERATECHNOLOGIES INC COM THER Stock Holding History

Royce & Associates’s Portfolio THER Stock Details THER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$25K – 1104
2020
Q4 		$25K Hold
10,000
– – ﹤0.01% 994
2020
Q3 		$22K Hold
10,000
– – ﹤0.01% 985
2020
Q2 		$20K Hold
10,000
– – ﹤0.01% 1118
2020
Q1 		$16K Hold
10,000
– – ﹤0.01% 1110
2019
Q4 		$33K Buy
+10,000
New +$33K ﹤0.01% 1077

Other funds holding THER

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royce & Associates's THER Position: Q1 2021 in Review

Royce & Associates sold out of THERATECHNOLOGIES INC COM (THER) in Q1 2021, closing a stake of 10,000 shares — an estimated $25K sold.

Royce & Associates first reported a position in THER in Q4 2019 and held it in 5 quarters. The position peaked at $33K in Q4 2019. 42 funds tracked by Wall St. Rank hold THER as of Q1 2021.

  • Royce & Associates reported no remaining THERATECHNOLOGIES INC COM position as of Q1 2021 after selling out during the quarter.
  • Royce & Associates sold 10,000 THERATECHNOLOGIES INC COM shares in Q1 2021, an estimated $25K.
  • Royce & Associates first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 5 quarters.
  • Royce & Associates's THERATECHNOLOGIES INC COM position peaked at $33K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q1 2021.

Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.